Chronic Kidney Disease

Patients who had frequent nephrologist appointments several months before beginning dialysis had reduced risk for adverse cardiovascular events 1 year after initiation, according to a published study.

The FDA granted fast track designation for the development of Farxiga for patients with chronic kidney disease, according to a press release from AstraZeneca.

Cricket Health has appointed a chief development officer and a new member to its board of directors.

The FDA granted fast track designation for the SGLT2 inhibitor dapagliflozin for use in patients with or without diabetes who have chronic kidney disease to delay progression of renal failure and to prevent cardiovascular and renal death, according to a press release from AstraZeneca.

ORLANDO — Patients with uncontrolled gout are more likely to develop chronic kidney disease, diabetes and heart disease compared with those with controlled disease, according to a poster presentation at the 2019 Rheumatology Nurses Society Annual Conference.

As the structure grows internally for Kidney Disease: Improving Global Outcomes, the nonprofit organization has work in the pipeline that includes new guidelines under development, outdated guidelines under revision and changes in process to make work more efficient and accessible. John Davis, the CEO of Kidney Disease: Improving Global Outcome (KDIGO), shared the new and update guidelines and processes in the works with Nephrology News & Issues.

Sustained virologic response after treatment for hepatitis C correlated with a reduced risk for several extrahepatic manifestations including type 2 diabetes, chronic kidney disease, and mood and anxiety disorders.

Balancing long-term risks and benefits of potentially toxic therapies, while achieving a cure, remains a delicate challenge in cancer treatment.

In a recent webinar, CMS offered more details on four new voluntary kidney payment models that are part of the Advancing American Kidney Health initiative.

SEATTLE — A new care model underway by pharmacy company CVS and health care insurer Aetna is using nurse practitioners stationed at pharmacies across the country to identify and manage patients with chronic kidney disease.